• Curing Diabetes, stem cells, diabetes, cure, hypertension, obesity, harvard, cdc, genomic revolution, ARKG, arkgenome, ark, ark investment management, investing, ETFs

    Curing Diabetes with Stem Cells

    by | Health
    Mentioned Companies: LLY, MRK, NVO, SNY

    New research out of Harvard University’s Stem Cell Institute may have cracked the code to curing diabetes. In a break-through study, scientists were able to turn human embryonic stem cells into fully mature insulin-producing beta cells and implant them into living tissue. While currently only in animals, these studies, if successful in humans, could point […]

  • pharmaceutical industry, insilico, in-silico, biotechnology, bio-inspired computing, ARK, ARK Investment Management, Innovation, ETF, Active management, thematic, investing, disruptive innovation, investment management, arkg, genome, genomic revolution, arkgenome

    An Oasis in the Wasteland: Can In-Silico Drug Discovery Help Save Pharma?

    by | Health
    Mentioned Companies: BIIB, LLY

    Advances in algorithmic science and cloud computing could increase the success rate of drug discovery in the pharmaceutical industry, while considerably reducing costs. Given the size of R&D spending in the pharmaceutical industry, and its current low success rate, the positive impact on profits could be dramatic. Over the past ten years the pharmaceutical industry […]